Olcay Aydıntuğ

733 total citations
20 papers, 426 citations indexed

About

Olcay Aydıntuğ is a scholar working on Rheumatology, Ophthalmology and Hematology. According to data from OpenAlex, Olcay Aydıntuğ has authored 20 papers receiving a total of 426 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Rheumatology, 7 papers in Ophthalmology and 5 papers in Hematology. Recurrent topics in Olcay Aydıntuğ's work include Systemic Lupus Erythematosus Research (7 papers), Ocular Diseases and Behçet’s Syndrome (7 papers) and Vasculitis and related conditions (3 papers). Olcay Aydıntuğ is often cited by papers focused on Systemic Lupus Erythematosus Research (7 papers), Ocular Diseases and Behçet’s Syndrome (7 papers) and Vasculitis and related conditions (3 papers). Olcay Aydıntuğ collaborates with scholars based in Türkiye, United States and Iran. Olcay Aydıntuğ's co-authors include Nurşen Düzgün, Murat Duman, Hüseyin Tutkak, Hülya Çetınkaya, İrfan Soykan, Murat Törüner, Nuran Türkçapar, Ali Özden, Ergin Ayaşlıoğlu and Ümit Ölmez and has published in prestigious journals such as Journal of Medical Virology, International Journal of Cardiology and Postgraduate Medical Journal.

In The Last Decade

Olcay Aydıntuğ

20 papers receiving 413 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olcay Aydıntuğ Türkiye 11 231 108 102 95 89 20 426
Hoda Kavosi Iran 14 172 0.7× 111 1.0× 245 2.4× 108 1.1× 27 0.3× 51 636
Lale Öçal Türkiye 16 456 2.0× 68 0.6× 39 0.4× 266 2.8× 42 0.5× 39 754
A. Hamzaoui Tunisia 10 130 0.6× 38 0.4× 148 1.5× 54 0.6× 15 0.2× 54 339
S Lassoued France 11 106 0.5× 89 0.8× 22 0.2× 46 0.5× 47 0.5× 37 323
M. Khanfir Tunisia 15 275 1.2× 58 0.5× 339 3.3× 95 1.0× 13 0.1× 68 604
N. Ortego Spain 8 226 1.0× 37 0.3× 234 2.3× 75 0.8× 16 0.2× 23 456
Luisa Praderio Italy 11 261 1.1× 142 1.3× 26 0.3× 257 2.7× 15 0.2× 24 647
Antonio Bañares Spain 11 543 2.4× 47 0.4× 246 2.4× 108 1.1× 22 0.2× 13 801
GSRSNK Naidu India 13 166 0.7× 63 0.6× 14 0.1× 66 0.7× 27 0.3× 66 493
S. Bucciarelli Spain 8 323 1.4× 17 0.2× 19 0.2× 61 0.6× 69 0.8× 9 414

Countries citing papers authored by Olcay Aydıntuğ

Since Specialization
Citations

This map shows the geographic impact of Olcay Aydıntuğ's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olcay Aydıntuğ with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olcay Aydıntuğ more than expected).

Fields of papers citing papers by Olcay Aydıntuğ

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olcay Aydıntuğ. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olcay Aydıntuğ. The network helps show where Olcay Aydıntuğ may publish in the future.

Co-authorship network of co-authors of Olcay Aydıntuğ

This figure shows the co-authorship network connecting the top 25 collaborators of Olcay Aydıntuğ. A scholar is included among the top collaborators of Olcay Aydıntuğ based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olcay Aydıntuğ. Olcay Aydıntuğ is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Düzgün, Nurşen, et al.. (2008). Thymidylate synthase genotype and serum concentrations of homocysteine and folate in Behçet’s disease. Clinical Rheumatology. 27(10). 1221–1225. 5 indexed citations
2.
Gürsoy, Alptekin, et al.. (2007). Prevalence and clinical significance of antineutrophil cytoplasmic antibody in Graves’ patients treated with propylthiouracil. International Journal of Clinical Practice. 63(2). 299–302. 26 indexed citations
3.
Atmaca-Sönmez, Pelin, Leyla S. Atmaca, & Olcay Aydıntuğ. (2007). Update on ocular Behçet’s disease. Expert Review of Ophthalmology. 2(6). 957–979. 1 indexed citations
4.
Şahin, Mehmet, Olcay Aydıntuğ, Şevket Ercan Tunç, Hüseyin Tutkak, & Mustafa Nazıroğlu. (2006). Serum soluble Fas levels in patients with autoimmune rheumatic diseases. Clinical Biochemistry. 40(1-2). 6–10. 19 indexed citations
5.
Batıoğlu, Figen, et al.. (2006). Recurrent Optic Disc and Retinal Vasculitis in a Patient with Drug-Induced Urticarial Vasculitis. Cutaneous and Ocular Toxicology. 25(4). 281–285. 9 indexed citations
6.
Ateş, Aşkın, et al.. (2005). Urinary 8-isoprostaglandin F2α level in Behçet's disease. Prostaglandins & Other Lipid Mediators. 78(1-4). 96–106. 1 indexed citations
7.
Türkçapar, Nuran, Murat Törüner, İrfan Soykan, et al.. (2005). The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease. Rheumatology International. 26(7). 663–668. 123 indexed citations
8.
Ateş, Aşkın, et al.. (2004). Behçet's disease presenting as deep venous thrombosis and priapism.. PubMed. 22(1). 107–9. 8 indexed citations
9.
Ateş, Aşkın, Olcay Aydıntuğ, Ümit Ölmez, Nurşen Düzgün, & Murat Duman. (2003). Serum homocysteine level is higher in Behçet’s disease with vascular involvement. Rheumatology International. 25(1). 42–44. 39 indexed citations
10.
Kılıçkap, Mustafa, Eralp Tutar, Olcay Aydıntuğ, et al.. (2003). Increase in soluble E-selectin level after PTCA and stent implantation: a potential marker of restenosis. International Journal of Cardiology. 93(1). 13–18. 8 indexed citations
11.
Düzgün, Nurşen, Ergin Ayaşlıoğlu, Hüseyin Tutkak, & Olcay Aydıntuğ. (2003). Cytokine inhibitors: soluble tumor necrosis factor receptor 1 and interleukin-1 receptor antagonist in Behçet’s disease. Rheumatology International. 25(1). 1–5. 48 indexed citations
12.
Düzgün, Nurşen, et al.. (2003). Plasma thrombomodulin levels in patients with Behçet's disease. Rheumatology International. 23(3). 130–133. 6 indexed citations
13.
Idılman, Ramazan, Hülya Çetınkaya, İsmail Savaş, et al.. (2002). Bronchoalveolar lavage fluid analysis in individuals with chronic hepatitis C. Journal of Medical Virology. 66(1). 34–34. 3 indexed citations
14.
Idılman, Ramazan, Hülya Çetınkaya, İsmail Savaş, et al.. (2001). Bronchoalveolar lavage fluid analysis in individuals with chronic hepatitis C. Journal of Medical Virology. 66(1). 34–39. 36 indexed citations
15.
Topaloğlu, Rezan, et al.. (2001). Survey of Factor V Leiden and Prothrombin Gene Mutations in Systemic Lupus Erythematosus. Clinical Rheumatology. 20(4). 259–261. 14 indexed citations
16.
Topaloğlu, Rezan, Ayşı̇n Bakkaloğlu, Olcay Aydıntuğ, et al.. (2000). Survey of Turkish systemic lupus erythematosus patients for a particular mutation of C1Q deficiency.. PubMed. 18(1). 75–7. 12 indexed citations
17.
Şentürk, Tunay, Olcay Aydıntuğ, Işınsu Kuzu, et al.. (1998). Adhesion molecule expression in erythema nodosum-like lesions in Behçet's disease. Rheumatology International. 18(2). 51–57. 13 indexed citations
18.
Üstün, Celalettin, et al.. (1997). A case report of a patient who has pure red cell aplasia and rheumatoid arthritis.. PubMed. 66(4). 505–12. 5 indexed citations
19.
Tülek, Necla, Olcay Aydıntuğ, Kürşat Özoran, et al.. (1996). Soluble intercellular adhesion molecule-1 (sICAM-1) in patients with systemic lupus erythematosus. Clinical Rheumatology. 15(1). 47–50. 14 indexed citations
20.
Domenech, Ines, Olcay Aydıntuğ, Ricard Cervera, et al.. (1992). Systemic lupus erythematosus in 50 year olds. Postgraduate Medical Journal. 68(800). 440–444. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026